MyFinsight
Home
Blog
About
Contact
Download
Download image
Net gain
attributable to common...
-$510K
Net gain
attributable to common...
-$510K
US
$213,836K
Non Us
$2,338K
Net gain
-$510K
Income tax benefit
-$134K
Total revenue
$216,174K
Gain before income
taxes and income tax...
-$644K
Income (loss) from
operations
$5,282K
Total costs and
operating expenses
$210,892K
Total other expense,
net
-$5,926K
Interest income
$6,834K
Other income
(expense), net
$49K
Cost of
services-Molecular Profiling...
$72,884K
General and
administrative expense (see...
$59,708K
Selling and marketing
expense
$45,043K
Research and development
expense
$31,315K
Cost of
services-Pharma Research And...
$1,942K
Interest expense
$12,809K
Back
Back
Income Statement
source: myfinsight.com
Caris Life Sciences, Inc. (CAI)
Caris Life Sciences, Inc. (CAI)